Advisers & FriendsPaul J. Hagerman, M.D.
|
Clinical/Research InterestsPaul J. Hagerman, a molecular biologist with particular expertise in nucleic acid biochemistry, was recruited to the M.I.N.D. Institute and the Department of Biological Chemistry from the University of Colorado School of Medicine. He has spearheaded development of the M.I.N.D. Institute's new $1 million neurodevelopmental genomics laboratory, and will take the lead in developing a comprehensive biomarkers research program. The goal of the biomarkers program is to identify biochemical identifiers (markers) of autism and other neurodevelopmental disorders. Such biomarkers will be useful in the short term to identify children who may be predisposed to develop autism; however, the ultimate goal of the program is the development of more effective treatments for autism and related disorders. Hagerman received both his M.D. and Ph.D. degrees from Stanford University School of Medicine in 1977. This was followed by a three-year Leukemia Society Fellowship at UCSD, where he began his studies of nucleic acid structure. He joined the University of Colorado in 1980, where he remained until joining the UC Davis faculty. Hagerman is currently on the scientific advisory board of the Muscular Dystrophy Association, and recently shifted toward the study of the molecular biology of neurodevelopmental disorders, with particular emphasis on fragile X syndrome--the leading heritable form of mental retardation. Since joining the Davis faculty, Hagerman has expanded his research efforts to include investigations of the underlying biochemical and genetic causes of autism. |
Title: |
Professor |
Specialty: |
Biological Chemistry |
Center/Program Affiliation: |
UC Davis MIND Institute |
Education: |
Stanford University School of Medicine Palo Alto, California M.D. |
